Basic information Safety Supplier Related

Tert-butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate

Basic information Safety Supplier Related

Tert-butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate Basic information

Product Name:
Tert-butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate
Synonyms:
  • Tert-butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate
  • tert-butyl 2,4-dichloro-5,6,8,9-tetrahydro-7H-pyrimido[4,5-d]azepine-7-carboxylate
  • 7-Boc-2,4-dichloro-5,6,8,9-tetrahydropyrimido[4,5-d]azepine
  • 7H-Pyrimido[4,5-d]azepine-7-carboxylic acid, 2,4-dichloro-5,6,8,9-tetrahydro-, 1,1-dimethylethyl ester
CAS:
1065114-27-3
MF:
C13H17Cl2N3O2
MW:
318.2
Mol File:
1065114-27-3.mol
More
Less

Tert-butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate Chemical Properties

Boiling point:
436.6±45.0 °C(Predicted)
Density 
1.311±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-1.68±0.20(Predicted)
Appearance
White to off-white Solid
More
Less

Safety Information

HS Code 
2933998090
More
Less

Tert-butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate Usage And Synthesis

Synthesis

1065114-25-1

24424-99-5

1065114-27-3

The general procedure for the synthesis of 7-BOC-2,4-dichloro-5,6,8,9-pyrimido[4,5-d]azepine-7-carboxylic acid from tert-butyl 4-oxo-2-thioxo-1,2,3,4,5,6,8,9-octahydro-7H-pyrimido[4,5-D]aza-7-carboxylate and di-tert-butyl dicarbonate was carried out as follows: to the product of step A (300 g, 1.01 mol) to a solution of phosphorus oxychloride (POCl3, 1500 mL) was added N,N-dimethylformamide (DMF, 10 mL). The reaction mixture was heated at 90 °C until thin layer chromatography (TLC) analysis (unfolding agent: ethyl acetate/petroleum ether = 1:2) showed complete consumption of the raw material. Excess POCl3 was removed under vacuum and the residue was slowly poured into crushed ice under stirring. The pH of the aqueous solution was adjusted to 8 with solid potassium carbonate (K2CO3) and a solution of di-tert-butyl dicarbonate ((Boc)2O, 235 g, 1.09 mol) and triethylamine (Et3N, 600 mL) in tetrahydrofuran (THF, 1 L) was added. The reaction mixture was stirred at room temperature overnight until TLC analysis (unfolding agent: ethyl acetate/petroleum ether = 1:25) showed complete consumption of the raw material. THF was removed under vacuum and the aqueous solution was extracted with dichloromethane (CH2Cl2, 1L x 3). The organic layers were combined, washed with brine, dried over anhydrous sodium sulfate (Na2SO4) and concentrated to give the crude product. The crude product was purified by column chromatography (eluent: ethyl acetate/petroleum ether=1:25) to afford the target product (44 g, 14% yield) as a white solid.1H NMR (400 MHz, CDCl3) δppm: 1.46 (s, 9H), 3.03-3.10 (m, 4H), 3.56 (bs, 4H).

References

[1] Patent: WO2008/117169, 2008, A1. Location in patent: Page/Page column 169

Tert-butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylateSupplier

Shanghai Boc Chemical Co.,Ltd
Tel
021-34975603-808 18721111801
Email
sales@bocpharma.com
Shanghai Jian Chao Chemical Technology Co., Ltd.
Tel
150-2103-5486 18017383231
Email
983544897@qq.com
Shanghai Chainpharm Bio-medical Technology Co., Ltd.
Tel
+86-021-61727342 13611721451
Email
chainpharm@163.com
Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Email
product02@bidepharm.com
Porse Fine Chemical Co.,LTD
Tel
20-66003216 18666003216
Email
info@porsefinechemical.com
More
Less